Kawthar K Abla (Kawthar Abla)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Chronic Rhinosinusitis

Endothelial Cells

Top Venues

Gels (Basel, Switzerland)

Molecular pharmaceutics

Therapeutic delivery

Pharmaceutical development and technology

This page only lists publications with an associated author ORCID identifier.

Publications

Nesrine Ahmad, Georges Kiriako, John Saliba, Kawthar K Abla, Marwan El-Sabban, Rami Mhanna
Engineering a 3D Biomimetic Peptides Functionalized-Polyethylene Glycol Hydrogel Model Cocultured with Endothelial Cells and Astrocytes: Enhancing In Vitro Blood-Brain Barrier Biomimicry. Molecular pharmaceutics (2024)
Nesrine Ahmad, Georges Kiriako, John Saliba, Kawthar K Abla, Marwan El-Sabban, Rami Mhanna
Engineering a 3D Biomimetic Peptides Functionalized-Polyethylene Glycol Hydrogel Model Cocultured with Endothelial Cells and Astrocytes: Enhancing In Vitro Blood-Brain Barrier Biomimicry. Molecular pharmaceutics 21 (9) (2024)
Kawthar K Abla, Souraya A Domiati, Rania El Majzoub, Mohammed M Mehanna
Propranolol-Loaded Limonene-Based Microemulsion Thermo-Responsive Mucoadhesive Nasal Nanogel: Design, In Vitro Assessment, Ex Vivo Permeation, and Brain Biodistribution. Gels (Basel, Switzerland) 9 (6) (2023)
Kawthar K Abla, Souraya A Domiati, Rania El Majzoub, Mohammed M Mehanna
Propranolol-Loaded Limonene-Based Microemulsion Thermo-Responsive Mucoadhesive Nasal Nanogel: Design, In Vitro Assessment, Ex Vivo Permeation, and Brain Biodistribution. Gels (Basel, Switzerland) 9 (6) (2023)
Kawthar K Abla, Souraya A Domiati, Rania El Majzoub, Mohammed M Mehanna
Propranolol-Loaded Limonene-Based Microemulsion Thermo-Responsive Mucoadhesive Nasal Nanogel: Design, In Vitro Assessment, Ex Vivo Permeation, and Brain Biodistribution. Gels (Basel, Switzerland) 9 (6) (2023)
Mohammed M Mehanna, Kawthar K Abla
Recent advances in freeze-drying: variables, cycle optimization, and innovative techniques. Pharmaceutical development and technology 27 (8) (2022)
Mohammed M Mehanna, Kawthar K Abla
siRNA nanohybrid systems: false hope or feasible answer in cancer management. Therapeutic delivery 13 (2) (2022)